Invasive ductal carcinoma of the breast in a pregnant woman: case report

Autores

DOI:

https://doi.org/10.29289/2594539420220011

Palavras-chave:

pregnant woman, breast cancer, invasive ductal carcinoma, pregnancy

Resumo

Gestational breast cancer is the most common cause of cancer in pregnant women. It is a challenging condition for the medical team, since the physiological changes in the breast during this period increase the density of the breast parenchyma, which makes it difficult to detect the nodule on physical and imaging examination, causing delay in diagnosis. We present here a case report of a woman with breast cancer diagnosed during pregnancy. This was a 28-year-old female patient who arrived at the service at 14 weeks’ gestation, diagnosed with invasive ductal carcinoma in the left breast, with T4dN2M0 staging. Neoadjuvant chemotherapy treatment was started with a pause for the cesarean section at 36 weeks’ gestation. After delivery, chemotherapy was restarted, followed by radical mastectomy, radiotherapy and hormone therapy. Two years after the initial diagnosis and still being treated with hormone therapy, the patient presented with musculoskeletal pain, detected on magnetic resonance imaging and bone scintigraphy, as well as several points of metastasis in the spine with pathological fracture of L2-L3, where she was then submitted to decompressive laminectomy. After surgery, radiotherapy of the thoracic and lumbar spine was started, in addition to chemotherapy. Currently, the patient is asymptomatic, being on paclitaxel and transtuzumab, with stable bone scintigraphy and radiography and ultrasound showing no metastases, and the child is healthy after three years of follow-up.

Downloads

Não há dados estatísticos.

Referências

Shlensky V, Hallmeyer S, Juarez L, Parilla BV. Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines? AJP Rep. 2017;7(1):e39-43. https://doi.org/10.1055/s-0037-1599133

Filho LAM, Bom AGC, Ferreira CRS, Chagas JMA, Santos LCH, Oliveira LF, et al. Câncer de mama gestacional: enfoque diagnóstico e terapêutico. REAC. 2021;34:3-7. https://doi.org/10.25248/REAC.e8675.2021

Sánchez MCG, Díaz CMM, Gallardo MB, Ageitos AG, Antón MAH, Díaz ES. Tratamiento neoayuvante en el cáncer de mama gestacional. Neoadjuvant therapy in gestational breast cancer. Prog Obstet Ginecol. 2017 [cited on Jul 11, 2017];60(6):594-6. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/ibc-171149

4. Sham TWG, Man CMV, Chow CYL, Co THM, Kwong A. Pregnancy-related breast cancer: 13-year experience in a tertiary institution in Hong Kong. Surgical Practice. 2021[cited on Sep 19, 2020]. Available from: https://hub.hku.hk/handle/10722/297192

5. Aktoz F, Yalcin AC, Yüzdemir HS, Akata D, Gültekin M. Treatment of massive liver metastasis of breast cancer during pregnancy: first report of a complete remission with trastuzumab and review of literature. J Matern Fetal Neonatal Med. 2020;33(7):1266-71. https://doi.org/10.1080/14767058.2018.1517308

6. Ye X, He Q, Zhou X. Study on the adverse effects following chemotherapy for breast cancer diagnosis during pregnancy: The first case report in China. Medicine (Baltimore). 2017;96(46):e8582. https://doi.org/10.1097/MD.0000000000008582

7. Sugai S, Sakata E, Kurabayashi T. Low back pain as an initial symptom of pregnancy-associated breast cancer: a case report. BMC Womens Health. 2021;21(1):153. https://doi.org/10.1186/s12905-021-01298-1

8. Tang T, Liu Y, Yang C, Ma L. Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female: a case report. Medicine (Baltimore). 2020;99(44):e22929. https://doi.org/10.1097/MD.0000000000022929

9. Cabral KMAA, Ferreira ACV, Silva AFSS, Costa ALM. Breast câncer in a 23-year-old nursing mother – case report. Mastology (Online). 2020;30(Suppl 1):8. https://doi.org/10.29289/259453942020V30S1008

10. Sanvido VM, Simomoto MM, Nazário ACP. Pregnancy-associated breast cancer – case report. Mastology (Online). 2020;30(Suppl 1):86. https://doi.org/10.29289/259453942020V30S1086

11. Boere I, Lok C, Poortmans P, Koppert L, Painter R, Vd Heuvel-Eibrink MM, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol. 2022;82:46-59. https://doi.org/10.1016/j.bpobgyn.2022.05.001

12. Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R. Use of tamoxifen before and during pregnancy. Oncologist. 2011;16(11):1547-51. https://doi.org/10.1634/theoncologist.2011-0121

13. Ved N, Curran A, Ashcroft FM, Sparrow DB. Tamoxifen administration in pregnant mice can be deleterious to both mother and embryo. Lab Anim. 2019;53(6):630-3. https://doi.org/10.1177/0023677219856918

14. Macdonald HR. Pregnancy associated breast cancer. Breast J. 2020;26(1):81-5. https://doi.org/10.1111/tbj.13714

15. Cardoso GBS. Pregnancy-associated breast câncer: Analysis of cases in the mastology service of hospital Santa Marcelina de Itaquera, São Paulo, from 2014 to 2019. 2020;30(Suppl 1):87. https://doi.org/10.29289/259453942020V30S1087

16. Monteiro DLM, Nunes CL, Rodrigues NCP, Antunes CA, Almeida EM, Barmpas DBS, et al. Fatores associados ao câncer de mama gestacional: estudo caso-controle. Ciênc Saúde Colet. 2019;24(6): 2361-9. https://doi.org/10.1590/1413-81232018245.18392017

Downloads

Publicado

2026-04-17

Como Citar

Brasileiro, M. P. P., Carlon, M. B., & Dair, E. L. (2026). Invasive ductal carcinoma of the breast in a pregnant woman: case report. Mastology, 32. https://doi.org/10.29289/2594539420220011

Edição

Seção

Case Reports